Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lishitonglin Formula for Preoperative UTIs in Urethral Stricture
NCT07769060Phase 2Active, not recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jan 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in urinary tract infection (UTI) and urethral stricture (4 arms), sponsored by Peking University First Hospital. Primary endpoint: Bacterial clearance rate. Started Jan 2026; status: active, not recruiting.
02
Conditions
urinary tract infection (UTI)urethral stricture
Beyond the preview
Go deeper on NCT07769060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07769060.